DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Articles in academic journal >

High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells.


File Description SizeFormat
EJP659_67.pdf314.45 kBAdobe PDFView/Open

Title: High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells.
Authors: Nakamura, Shigeki / Yanagihara, Katsunori / Araki, Nobuko / Yamada, Koichi / Morinaga, Yoshitomo / Izumikawa, Koichi / Seki, Masafumi / Kakeya, Hiroshi / Yamamoto, Yoshihiro / Kamihira, Shimeru / Kohno, Shigeru
Issue Date: 20-May-2011
Publisher: Elsevier B.V.
Citation: European journal of pharmacology, 659(1), pp.67-71; 2011
Abstract: Tobramycin inhalation therapy is an effective therapy for cystic fibrosis as well as severe bronchiectasis that is colonized with Pseudomonas aeruginosa. The mechanism responsible for the efficacy of tobramycin in the treatment of severe chronic infectious diseases has not been elucidated. We demonstrate that high-dose tobramycin decreases MUC5AC gene expression and protein production in NCI-H292 cell stimulated with lipopolysaccharide of P. aeruginosa. MUC5AC protein of NCI-H292 cell stimulated by lipopolysaccharide was analyzed by an enzyme-linked immunosorbent assay and MUC5AC expression at the mRNA level was analyzed by RT-PCR. Western blot was performed to examine a potential role for the signaling molecules upstream of NFκB. High-dose tobramycin (500μg/ml) decreased the level of MUC5AC protein released into the supernatant of the NCI-H292 cell line at 24h after lipopolysaccharide stimulation (P<0.001). The tobramycin treatment also inhibited MUC5AC mRNA expression at 12h after lipopolysaccharide stimulation (P<0.05) and suppressed NFκB activation 60min after lipopolysaccharide stimulation (P<0.001). Tobramycin suppressed the phosphorylation of extracellular signal-regulated protein kinase, p38 MAP kinase. These results suggest that high-dose tobramycin, such as inhalation therapy, can inhibit MUC5AC gene expression and MUC5AC protein production in NCI-H292 cells, in part through the mitogen-activated protein kinase pathway. Thus, the activation of TLR4 and the subsequent immune/inflammatory responses induced by chronic infections such as P. aeruginosa might be modulated by tobramycin. Our data may reveal one of the mechanisms responsible for the clinical effect of tobramycin inhalation therapy against severe chronic respiratory diseases due to P. aeruginosa.
Keywords: Bronchial cell / High-dose tobramycin / Lipopolysaccharide / Mitogen-activated protein kinase pathway / MUC5AC / Pseudomonas aeruginosa
URI: http://hdl.handle.net/10069/25418
ISSN: 00142999
DOI: 10.1016/j.ejphar.2011.03.002
PubMed ID: 21414310
Rights: © 2011 Elsevier B.V. All rights reserved.
Type: Journal Article
Text Version: author
Appears in Collections:Articles in academic journal

Citable URI : http://hdl.handle.net/10069/25418

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace